MDGL — Madrigal Pharmaceuticals inc

Ownership history in MPM BioImpact LLC  ·  14 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Madrigal Pharmaceuticals inc (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
7.54% (2025 Q3)
Avg. % of fund
3.18%
First filed
2022 Q2
Last filed
2025 Q4
Quarters held
14
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 96,780 -3,635 -3.6% 6.45% $56.4M $582.34
2025 Q3 UNCHANGED 100,415 — 0% 7.54% $46.1M $458.66
2025 Q2 UNCHANGED 100,415 — 0% 5.27% $30.4M $302.64
2025 Q1 ADDED 100,415 +28,020 +38.7% 5.72% $33.3M $331.23
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MDGL price (monthly, adj. close)

Other funds also holding MDGL

As of 2025 Q4 — sorted by position size

PAULSON & CO. INC. 3Y 7Y 30.48% RTW INVESTMENTS, LP 3Y 7Y 11.63% Tao Capital Management LP 3Y 10.53% Avoro Capital Advisors LLC 3Y 7Y 10.35% BAKER BROS. ADVISORS LP 3Y 7Y 7.3% Tri Locum Partners LP 3Y 6.5% Nan Fung Group Holdings Ltd 3Y 6.19% Rock Springs Capital Management LP 3Y 7Y 4.17% Resolute Capital Asset Partners LLC 3Y 3.07% First Light Asset Management, LLC 3Y 7Y 2.98%
← Back to MPM BioImpact LLC Holdings